Evolus Valuation
| EOLS Stock | USD 13.80 0.97 7.56% |
At this time, the firm appears to be undervalued. Evolus Inc shows a prevailing Real Value of $17.23 per share. The current price of the firm is $13.8. Our model computes the value of Evolus Inc from reviewing the firm fundamentals such as Current Valuation of 918.68 M, profit margin of (0.22) %, and Shares Outstanding of 63.32 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Evolus' valuation include:
Price Book 148.3594 | Enterprise Value 918.7 M | Enterprise Value Ebitda (21.50) | Price Sales 3.5189 | Forward PE 106.383 |
Undervalued
Today
Please note that Evolus' price fluctuation is not too volatile at this time. Calculation of the real value of Evolus Inc is based on 3 months time horizon. Increasing Evolus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Evolus stock is determined by what a typical buyer is willing to pay for full or partial control of Evolus Inc. Since Evolus is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Evolus Stock. However, Evolus' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.8 | Real 17.23 | Target 20.25 | Hype 13.67 | Naive 15.33 |
The intrinsic value of Evolus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Evolus' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Evolus Inc helps investors to forecast how Evolus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Evolus more accurately as focusing exclusively on Evolus' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Evolus' intrinsic value based on its ongoing forecasts of Evolus' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Evolus' closest peers.
Evolus Cash |
|
Evolus Valuation Trend
Evolus' real value is important for investors to make better decisions and a more accurate overall view of Evolus' financial worth over time. Using both Evolus' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Evolus Revenue by Product
Evolus Total Value Analysis
Evolus Inc is currently expected to have valuation of 918.68 M with market capitalization of 873.84 M, debt of 126.55 M, and cash on hands of 84.48 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Evolus fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
918.68 M | 873.84 M | 126.55 M | 84.48 M |
Evolus Investor Information
About 12.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.91. Evolus Inc had not issued any dividends in recent years. Based on the key indicators related to Evolus' liquidity, profitability, solvency, and operating efficiency, Evolus Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Evolus Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Evolus has an asset utilization ratio of 106.92 percent. This implies that the Company is making $1.07 for each dollar of assets. An increasing asset utilization means that Evolus Inc is more efficient with each dollar of assets it utilizes for everyday operations.Evolus Ownership Allocation
Evolus holds a total of 63.32 Million outstanding shares. The majority of Evolus Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Evolus Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Evolus. Please pay attention to any change in the institutional holdings of Evolus Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Evolus Profitability Analysis
The company reported the previous year's revenue of 202.09 M. Net Loss for the year was (61.69 M) with profit before overhead, payroll, taxes, and interest of 92.73 M.About Evolus Valuation
The stock valuation mechanism determines Evolus' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Evolus Inc based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Evolus. We calculate exposure to Evolus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Evolus's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 140.5 M | 147.6 M | |
| Pretax Profit Margin | (0.30) | (0.32) | |
| Operating Profit Margin | (0.24) | (0.26) | |
| Net Loss | (0.31) | (0.32) | |
| Gross Profit Margin | 0.70 | 0.74 |
Evolus Growth Indicators
Investing in growth stocks can be very risky. If the company such as Evolus does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 56.9 M | |
| Forward Price Earnings | 106.383 |
Evolus Current Valuation Indicators
Evolus' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Evolus' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Evolus, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Evolus' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Evolus' worth.Additional Tools for Evolus Stock Analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.